nodes	percent_of_prediction	percent_of_DWPC	metapath
Linagliptin—CYP3A4—Pimecrolimus—atopic dermatitis	0.0937	0.122	CbGbCtD
Linagliptin—ABCB1—Tacrolimus—atopic dermatitis	0.093	0.121	CbGbCtD
Linagliptin—ABCB1—Loratadine—atopic dermatitis	0.0681	0.0888	CbGbCtD
Linagliptin—ABCB1—Methylprednisolone—atopic dermatitis	0.0623	0.0813	CbGbCtD
Linagliptin—CYP3A4—Tacrolimus—atopic dermatitis	0.0557	0.0727	CbGbCtD
Linagliptin—CYP3A4—Loratadine—atopic dermatitis	0.0408	0.0532	CbGbCtD
Linagliptin—ABCB1—Betamethasone—atopic dermatitis	0.0405	0.0528	CbGbCtD
Linagliptin—ABCB1—Prednisolone—atopic dermatitis	0.04	0.0521	CbGbCtD
Linagliptin—ABCB1—Hydrocortisone—atopic dermatitis	0.0379	0.0494	CbGbCtD
Linagliptin—ABCB1—Prednisone—atopic dermatitis	0.0377	0.0492	CbGbCtD
Linagliptin—CYP3A4—Methylprednisolone—atopic dermatitis	0.0373	0.0487	CbGbCtD
Linagliptin—CYP3A4—Triamcinolone—atopic dermatitis	0.0283	0.0369	CbGbCtD
Linagliptin—CYP3A4—Betamethasone—atopic dermatitis	0.0243	0.0317	CbGbCtD
Linagliptin—CYP3A4—Prednisolone—atopic dermatitis	0.0239	0.0312	CbGbCtD
Linagliptin—ABCB1—Dexamethasone—atopic dermatitis	0.0236	0.0307	CbGbCtD
Linagliptin—CYP3A4—Hydrocortisone—atopic dermatitis	0.0227	0.0296	CbGbCtD
Linagliptin—CYP3A4—Prednisone—atopic dermatitis	0.0226	0.0295	CbGbCtD
Linagliptin—CYP3A4—Dexamethasone—atopic dermatitis	0.0141	0.0184	CbGbCtD
Linagliptin—Pancreatitis acute—Prednisone—atopic dermatitis	0.00177	0.00759	CcSEcCtD
Linagliptin—Cough—Desonide—atopic dermatitis	0.00175	0.0075	CcSEcCtD
Linagliptin—Hypoglycaemia—Fluocinolone Acetonide—atopic dermatitis	0.00173	0.00739	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Desonide—atopic dermatitis	0.0017	0.00727	CcSEcCtD
Linagliptin—Immune system disorder—Fluocinonide—atopic dermatitis	0.00169	0.00722	CcSEcCtD
Linagliptin—Pain in extremity—Fluocinolone Acetonide—atopic dermatitis	0.00169	0.00722	CcSEcCtD
Linagliptin—Infection—Desonide—atopic dermatitis	0.00163	0.00697	CcSEcCtD
Linagliptin—Skin disorder—Desonide—atopic dermatitis	0.00159	0.00681	CcSEcCtD
Linagliptin—Nasopharyngitis—Fluocinolone Acetonide—atopic dermatitis	0.00151	0.00645	CcSEcCtD
Linagliptin—Diabetes mellitus—Tacrolimus—atopic dermatitis	0.00147	0.0063	CcSEcCtD
Linagliptin—Immune system disorder—Pimecrolimus—atopic dermatitis	0.00147	0.0063	CcSEcCtD
Linagliptin—Mediastinal disorder—Pimecrolimus—atopic dermatitis	0.00147	0.00628	CcSEcCtD
Linagliptin—Nasopharyngitis—Mometasone—atopic dermatitis	0.00144	0.00616	CcSEcCtD
Linagliptin—Hypertriglyceridaemia—Prednisone—atopic dermatitis	0.00143	0.0061	CcSEcCtD
Linagliptin—Malnutrition—Pimecrolimus—atopic dermatitis	0.00142	0.00607	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Fluocinonide—atopic dermatitis	0.00138	0.00589	CcSEcCtD
Linagliptin—Back pain—Pimecrolimus—atopic dermatitis	0.00137	0.00587	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Fluocinolone Acetonide—atopic dermatitis	0.00135	0.0058	CcSEcCtD
Linagliptin—Infection—Fluocinonide—atopic dermatitis	0.00132	0.00565	CcSEcCtD
Linagliptin—Hypoglycaemia—Tacrolimus—atopic dermatitis	0.00131	0.00562	CcSEcCtD
Linagliptin—Infestation NOS—Fluocinolone Acetonide—atopic dermatitis	0.0013	0.00556	CcSEcCtD
Linagliptin—Infestation—Fluocinolone Acetonide—atopic dermatitis	0.0013	0.00556	CcSEcCtD
Linagliptin—Angioedema—Pimecrolimus—atopic dermatitis	0.0013	0.00555	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Mometasone—atopic dermatitis	0.00129	0.00553	CcSEcCtD
Linagliptin—Skin disorder—Fluocinonide—atopic dermatitis	0.00129	0.00552	CcSEcCtD
Linagliptin—Pain in extremity—Tacrolimus—atopic dermatitis	0.00128	0.00548	CcSEcCtD
Linagliptin—Blood triglycerides increased—Prednisone—atopic dermatitis	0.00125	0.00535	CcSEcCtD
Linagliptin—Cough—Pimecrolimus—atopic dermatitis	0.00124	0.0053	CcSEcCtD
Linagliptin—Arthralgia—Pimecrolimus—atopic dermatitis	0.00121	0.00517	CcSEcCtD
Linagliptin—Urinary tract infection—Mometasone—atopic dermatitis	0.00121	0.00516	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Pimecrolimus—atopic dermatitis	0.0012	0.00513	CcSEcCtD
Linagliptin—Immune system disorder—Loratadine—atopic dermatitis	0.00117	0.00502	CcSEcCtD
Linagliptin—Anaphylactic shock—Pimecrolimus—atopic dermatitis	0.00116	0.00495	CcSEcCtD
Linagliptin—Infection—Pimecrolimus—atopic dermatitis	0.00115	0.00492	CcSEcCtD
Linagliptin—Skin disorder—Pimecrolimus—atopic dermatitis	0.00112	0.00481	CcSEcCtD
Linagliptin—Pancreatitis—Tacrolimus—atopic dermatitis	0.00109	0.00465	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Pimecrolimus—atopic dermatitis	0.00105	0.00451	CcSEcCtD
Linagliptin—Skin exfoliation—Hydrocortisone—atopic dermatitis	0.00105	0.0045	CcSEcCtD
Linagliptin—Mediastinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00105	0.0045	CcSEcCtD
Linagliptin—Rash—Desonide—atopic dermatitis	0.00103	0.00442	CcSEcCtD
Linagliptin—Dermatitis—Desonide—atopic dermatitis	0.00103	0.00442	CcSEcCtD
Linagliptin—Angioedema—Loratadine—atopic dermatitis	0.00103	0.00442	CcSEcCtD
Linagliptin—Headache—Desonide—atopic dermatitis	0.00103	0.00439	CcSEcCtD
Linagliptin—Constipation—Diphenhydramine—atopic dermatitis	0.00102	0.00438	CcSEcCtD
Linagliptin—Constipation—Dimenhydrinate—atopic dermatitis	0.00102	0.00438	CcSEcCtD
Linagliptin—Malnutrition—Fluocinolone Acetonide—atopic dermatitis	0.00102	0.00435	CcSEcCtD
Linagliptin—Weight increased—Tacrolimus—atopic dermatitis	0.00101	0.00431	CcSEcCtD
Linagliptin—Immune system disorder—Mometasone—atopic dermatitis	0.00101	0.00431	CcSEcCtD
Linagliptin—Mediastinal disorder—Mometasone—atopic dermatitis	0.001	0.0043	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.000999	0.00428	CcSEcCtD
Linagliptin—Constipation—Pimecrolimus—atopic dermatitis	0.00099	0.00424	CcSEcCtD
Linagliptin—Skin exfoliation—Triamcinolone—atopic dermatitis	0.00099	0.00424	CcSEcCtD
Linagliptin—Skin exfoliation—Methylprednisolone—atopic dermatitis	0.000987	0.00423	CcSEcCtD
Linagliptin—Infestation NOS—Tacrolimus—atopic dermatitis	0.000987	0.00423	CcSEcCtD
Linagliptin—Infestation—Tacrolimus—atopic dermatitis	0.000987	0.00423	CcSEcCtD
Linagliptin—Cough—Loratadine—atopic dermatitis	0.000986	0.00422	CcSEcCtD
Linagliptin—Back pain—Fluocinolone Acetonide—atopic dermatitis	0.000982	0.0042	CcSEcCtD
Linagliptin—Hypersensitivity—Fluocinonide—atopic dermatitis	0.000978	0.00419	CcSEcCtD
Linagliptin—Myalgia—Loratadine—atopic dermatitis	0.000962	0.00412	CcSEcCtD
Linagliptin—Urinary tract infection—Tacrolimus—atopic dermatitis	0.00096	0.00411	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Loratadine—atopic dermatitis	0.000955	0.00409	CcSEcCtD
Linagliptin—Urticaria—Diphenhydramine—atopic dermatitis	0.000951	0.00407	CcSEcCtD
Linagliptin—Urticaria—Dimenhydrinate—atopic dermatitis	0.000951	0.00407	CcSEcCtD
Linagliptin—Diabetes mellitus—Prednisolone—atopic dermatitis	0.000941	0.00403	CcSEcCtD
Linagliptin—Back pain—Mometasone—atopic dermatitis	0.000938	0.00401	CcSEcCtD
Linagliptin—Anaphylactic shock—Loratadine—atopic dermatitis	0.000922	0.00395	CcSEcCtD
Linagliptin—Urticaria—Pimecrolimus—atopic dermatitis	0.000919	0.00394	CcSEcCtD
Linagliptin—Diabetes mellitus—Hydrocortisone—atopic dermatitis	0.000919	0.00393	CcSEcCtD
Linagliptin—Skin exfoliation—Dexamethasone—atopic dermatitis	0.000898	0.00384	CcSEcCtD
Linagliptin—Skin exfoliation—Betamethasone—atopic dermatitis	0.000898	0.00384	CcSEcCtD
Linagliptin—Skin disorder—Loratadine—atopic dermatitis	0.000895	0.00383	CcSEcCtD
Linagliptin—Cough—Fluocinolone Acetonide—atopic dermatitis	0.000886	0.00379	CcSEcCtD
Linagliptin—Angioedema—Mometasone—atopic dermatitis	0.000886	0.00379	CcSEcCtD
Linagliptin—Diabetes mellitus—Triamcinolone—atopic dermatitis	0.000865	0.0037	CcSEcCtD
Linagliptin—Arthralgia—Fluocinolone Acetonide—atopic dermatitis	0.000864	0.0037	CcSEcCtD
Linagliptin—Diabetes mellitus—Methylprednisolone—atopic dermatitis	0.000863	0.00369	CcSEcCtD
Linagliptin—Hypersensitivity—Pimecrolimus—atopic dermatitis	0.000853	0.00365	CcSEcCtD
Linagliptin—Cough—Mometasone—atopic dermatitis	0.000846	0.00362	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Loratadine—atopic dermatitis	0.00084	0.00359	CcSEcCtD
Linagliptin—Rash—Fluocinonide—atopic dermatitis	0.000837	0.00358	CcSEcCtD
Linagliptin—Dermatitis—Fluocinonide—atopic dermatitis	0.000836	0.00358	CcSEcCtD
Linagliptin—Headache—Fluocinonide—atopic dermatitis	0.000832	0.00356	CcSEcCtD
Linagliptin—Arthralgia—Mometasone—atopic dermatitis	0.000825	0.00353	CcSEcCtD
Linagliptin—Myalgia—Mometasone—atopic dermatitis	0.000825	0.00353	CcSEcCtD
Linagliptin—Infection—Fluocinolone Acetonide—atopic dermatitis	0.000823	0.00352	CcSEcCtD
Linagliptin—Diarrhoea—Dimenhydrinate—atopic dermatitis	0.000819	0.00351	CcSEcCtD
Linagliptin—Diarrhoea—Diphenhydramine—atopic dermatitis	0.000819	0.00351	CcSEcCtD
Linagliptin—Immune system disorder—Tacrolimus—atopic dermatitis	0.000801	0.00343	CcSEcCtD
Linagliptin—Mediastinal disorder—Tacrolimus—atopic dermatitis	0.000799	0.00342	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.000796	0.00341	CcSEcCtD
Linagliptin—Diarrhoea—Pimecrolimus—atopic dermatitis	0.000792	0.00339	CcSEcCtD
Linagliptin—Anaphylactic shock—Mometasone—atopic dermatitis	0.000791	0.00339	CcSEcCtD
Linagliptin—Constipation—Loratadine—atopic dermatitis	0.000788	0.00337	CcSEcCtD
Linagliptin—Infection—Mometasone—atopic dermatitis	0.000786	0.00336	CcSEcCtD
Linagliptin—Diabetes mellitus—Dexamethasone—atopic dermatitis	0.000785	0.00336	CcSEcCtD
Linagliptin—Diabetes mellitus—Betamethasone—atopic dermatitis	0.000785	0.00336	CcSEcCtD
Linagliptin—Skin exfoliation—Prednisone—atopic dermatitis	0.000782	0.00335	CcSEcCtD
Linagliptin—Malnutrition—Tacrolimus—atopic dermatitis	0.000771	0.0033	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Fluocinolone Acetonide—atopic dermatitis	0.000755	0.00323	CcSEcCtD
Linagliptin—Rash—Dimenhydrinate—atopic dermatitis	0.000755	0.00323	CcSEcCtD
Linagliptin—Rash—Diphenhydramine—atopic dermatitis	0.000755	0.00323	CcSEcCtD
Linagliptin—Dermatitis—Dimenhydrinate—atopic dermatitis	0.000754	0.00323	CcSEcCtD
Linagliptin—Dermatitis—Diphenhydramine—atopic dermatitis	0.000754	0.00323	CcSEcCtD
Linagliptin—Headache—Dimenhydrinate—atopic dermatitis	0.00075	0.00321	CcSEcCtD
Linagliptin—Headache—Diphenhydramine—atopic dermatitis	0.00075	0.00321	CcSEcCtD
Linagliptin—Back pain—Tacrolimus—atopic dermatitis	0.000746	0.00319	CcSEcCtD
Linagliptin—Rash—Pimecrolimus—atopic dermatitis	0.00073	0.00312	CcSEcCtD
Linagliptin—Dermatitis—Pimecrolimus—atopic dermatitis	0.000729	0.00312	CcSEcCtD
Linagliptin—Headache—Pimecrolimus—atopic dermatitis	0.000725	0.0031	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Mometasone—atopic dermatitis	0.000721	0.00309	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.000715	0.00306	CcSEcCtD
Linagliptin—Pancreatitis—Prednisolone—atopic dermatitis	0.000693	0.00297	CcSEcCtD
Linagliptin—Diabetes mellitus—Prednisone—atopic dermatitis	0.000684	0.00293	CcSEcCtD
Linagliptin—Pancreatitis—Hydrocortisone—atopic dermatitis	0.000677	0.0029	CcSEcCtD
Linagliptin—Cough—Tacrolimus—atopic dermatitis	0.000673	0.00288	CcSEcCtD
Linagliptin—Myalgia—Tacrolimus—atopic dermatitis	0.000657	0.00281	CcSEcCtD
Linagliptin—Arthralgia—Tacrolimus—atopic dermatitis	0.000657	0.00281	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000652	0.00279	CcSEcCtD
Linagliptin—Weight increased—Prednisolone—atopic dermatitis	0.000644	0.00275	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Hydrocortisone—atopic dermatitis	0.000642	0.00275	CcSEcCtD
Linagliptin—Pancreatitis—Triamcinolone—atopic dermatitis	0.000638	0.00273	CcSEcCtD
Linagliptin—Pancreatitis—Methylprednisolone—atopic dermatitis	0.000636	0.00272	CcSEcCtD
Linagliptin—Diarrhoea—Loratadine—atopic dermatitis	0.000631	0.0027	CcSEcCtD
Linagliptin—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.00063	0.0027	CcSEcCtD
Linagliptin—Weight increased—Hydrocortisone—atopic dermatitis	0.000629	0.00269	CcSEcCtD
Linagliptin—Infection—Tacrolimus—atopic dermatitis	0.000626	0.00268	CcSEcCtD
Linagliptin—Infestation—Hydrocortisone—atopic dermatitis	0.000616	0.00264	CcSEcCtD
Linagliptin—Infestation NOS—Hydrocortisone—atopic dermatitis	0.000616	0.00264	CcSEcCtD
Linagliptin—Skin disorder—Tacrolimus—atopic dermatitis	0.000612	0.00262	CcSEcCtD
Linagliptin—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.00061	0.00261	CcSEcCtD
Linagliptin—Upper respiratory tract infection—Triamcinolone—atopic dermatitis	0.000604	0.00259	CcSEcCtD
Linagliptin—Weight increased—Triamcinolone—atopic dermatitis	0.000592	0.00253	CcSEcCtD
Linagliptin—Weight increased—Methylprednisolone—atopic dermatitis	0.000591	0.00253	CcSEcCtD
Linagliptin—Rash—Loratadine—atopic dermatitis	0.000581	0.00249	CcSEcCtD
Linagliptin—Dermatitis—Loratadine—atopic dermatitis	0.000581	0.00249	CcSEcCtD
Linagliptin—Infestation NOS—Methylprednisolone—atopic dermatitis	0.000579	0.00248	CcSEcCtD
Linagliptin—Infestation—Methylprednisolone—atopic dermatitis	0.000579	0.00248	CcSEcCtD
Linagliptin—Headache—Loratadine—atopic dermatitis	0.000578	0.00247	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.000574	0.00246	CcSEcCtD
Linagliptin—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000567	0.00243	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000544	0.00233	CcSEcCtD
Linagliptin—Diarrhoea—Mometasone—atopic dermatitis	0.000541	0.00232	CcSEcCtD
Linagliptin—Constipation—Tacrolimus—atopic dermatitis	0.000538	0.0023	CcSEcCtD
Linagliptin—Weight increased—Dexamethasone—atopic dermatitis	0.000537	0.0023	CcSEcCtD
Linagliptin—Weight increased—Betamethasone—atopic dermatitis	0.000537	0.0023	CcSEcCtD
Linagliptin—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000522	0.00224	CcSEcCtD
Linagliptin—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000522	0.00223	CcSEcCtD
Linagliptin—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000519	0.00222	CcSEcCtD
Linagliptin—Pancreatitis—Prednisone—atopic dermatitis	0.000504	0.00216	CcSEcCtD
Linagliptin—Urticaria—Tacrolimus—atopic dermatitis	0.0005	0.00214	CcSEcCtD
Linagliptin—Immune system disorder—Hydrocortisone—atopic dermatitis	0.000499	0.00214	CcSEcCtD
Linagliptin—Rash—Mometasone—atopic dermatitis	0.000499	0.00214	CcSEcCtD
Linagliptin—Dermatitis—Mometasone—atopic dermatitis	0.000498	0.00213	CcSEcCtD
Linagliptin—Headache—Mometasone—atopic dermatitis	0.000496	0.00212	CcSEcCtD
Linagliptin—Malnutrition—Hydrocortisone—atopic dermatitis	0.000481	0.00206	CcSEcCtD
Linagliptin—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000469	0.00201	CcSEcCtD
Linagliptin—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000468	0.002	CcSEcCtD
Linagliptin—Weight increased—Prednisone—atopic dermatitis	0.000468	0.002	CcSEcCtD
Linagliptin—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000464	0.00199	CcSEcCtD
Linagliptin—Malnutrition—Methylprednisolone—atopic dermatitis	0.000452	0.00194	CcSEcCtD
Linagliptin—Angioedema—Prednisolone—atopic dermatitis	0.00045	0.00193	CcSEcCtD
Linagliptin—Angioedema—Hydrocortisone—atopic dermatitis	0.00044	0.00188	CcSEcCtD
Linagliptin—Back pain—Triamcinolone—atopic dermatitis	0.000438	0.00188	CcSEcCtD
Linagliptin—Diarrhoea—Tacrolimus—atopic dermatitis	0.000431	0.00184	CcSEcCtD
Linagliptin—Angioedema—Triamcinolone—atopic dermatitis	0.000414	0.00177	CcSEcCtD
Linagliptin—Angioedema—Methylprednisolone—atopic dermatitis	0.000413	0.00177	CcSEcCtD
Linagliptin—Myalgia—Hydrocortisone—atopic dermatitis	0.00041	0.00175	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000407	0.00174	CcSEcCtD
Linagliptin—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000402	0.00172	CcSEcCtD
Linagliptin—Rash—Tacrolimus—atopic dermatitis	0.000397	0.0017	CcSEcCtD
Linagliptin—Dermatitis—Tacrolimus—atopic dermatitis	0.000397	0.0017	CcSEcCtD
Linagliptin—Cough—Triamcinolone—atopic dermatitis	0.000395	0.00169	CcSEcCtD
Linagliptin—Headache—Tacrolimus—atopic dermatitis	0.000394	0.00169	CcSEcCtD
Linagliptin—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000393	0.00168	CcSEcCtD
Linagliptin—Infection—Hydrocortisone—atopic dermatitis	0.00039	0.00167	CcSEcCtD
Linagliptin—Myalgia—Triamcinolone—atopic dermatitis	0.000386	0.00165	CcSEcCtD
Linagliptin—Arthralgia—Methylprednisolone—atopic dermatitis	0.000385	0.00165	CcSEcCtD
Linagliptin—Myalgia—Methylprednisolone—atopic dermatitis	0.000385	0.00165	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000382	0.00164	CcSEcCtD
Linagliptin—Skin disorder—Hydrocortisone—atopic dermatitis	0.000382	0.00163	CcSEcCtD
Linagliptin—Angioedema—Betamethasone—atopic dermatitis	0.000376	0.00161	CcSEcCtD
Linagliptin—Angioedema—Dexamethasone—atopic dermatitis	0.000376	0.00161	CcSEcCtD
Linagliptin—Immune system disorder—Prednisone—atopic dermatitis	0.000372	0.00159	CcSEcCtD
Linagliptin—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.00037	0.00158	CcSEcCtD
Linagliptin—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000369	0.00158	CcSEcCtD
Linagliptin—Infection—Triamcinolone—atopic dermatitis	0.000367	0.00157	CcSEcCtD
Linagliptin—Infection—Methylprednisolone—atopic dermatitis	0.000367	0.00157	CcSEcCtD
Linagliptin—Skin disorder—Methylprednisolone—atopic dermatitis	0.000358	0.00153	CcSEcCtD
Linagliptin—Malnutrition—Prednisone—atopic dermatitis	0.000358	0.00153	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000358	0.00153	CcSEcCtD
Linagliptin—Myalgia—Dexamethasone—atopic dermatitis	0.00035	0.0015	CcSEcCtD
Linagliptin—Myalgia—Betamethasone—atopic dermatitis	0.00035	0.0015	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000339	0.00145	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000337	0.00144	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000336	0.00144	CcSEcCtD
Linagliptin—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000336	0.00144	CcSEcCtD
Linagliptin—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000336	0.00144	CcSEcCtD
Linagliptin—Infection—Dexamethasone—atopic dermatitis	0.000333	0.00143	CcSEcCtD
Linagliptin—Infection—Betamethasone—atopic dermatitis	0.000333	0.00143	CcSEcCtD
Linagliptin—Angioedema—Prednisone—atopic dermatitis	0.000327	0.0014	CcSEcCtD
Linagliptin—Urticaria—Prednisolone—atopic dermatitis	0.000319	0.00137	CcSEcCtD
Linagliptin—Urticaria—Hydrocortisone—atopic dermatitis	0.000312	0.00134	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000306	0.00131	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000306	0.00131	CcSEcCtD
Linagliptin—Myalgia—Prednisone—atopic dermatitis	0.000305	0.0013	CcSEcCtD
Linagliptin—Arthralgia—Prednisone—atopic dermatitis	0.000305	0.0013	CcSEcCtD
Linagliptin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000303	0.0013	CcSEcCtD
Linagliptin—Hypersensitivity—Prednisolone—atopic dermatitis	0.000296	0.00127	CcSEcCtD
Linagliptin—Urticaria—Triamcinolone—atopic dermatitis	0.000294	0.00126	CcSEcCtD
Linagliptin—Urticaria—Methylprednisolone—atopic dermatitis	0.000293	0.00125	CcSEcCtD
Linagliptin—Anaphylactic shock—Prednisone—atopic dermatitis	0.000292	0.00125	CcSEcCtD
Linagliptin—Infection—Prednisone—atopic dermatitis	0.00029	0.00124	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.00029	0.00124	CcSEcCtD
Linagliptin—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.00029	0.00124	CcSEcCtD
Linagliptin—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000289	0.00124	CcSEcCtD
Linagliptin—Skin disorder—Prednisone—atopic dermatitis	0.000284	0.00122	CcSEcCtD
Linagliptin—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000272	0.00117	CcSEcCtD
Linagliptin—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000272	0.00116	CcSEcCtD
Linagliptin—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000269	0.00115	CcSEcCtD
Linagliptin—Urticaria—Dexamethasone—atopic dermatitis	0.000267	0.00114	CcSEcCtD
Linagliptin—Urticaria—Betamethasone—atopic dermatitis	0.000267	0.00114	CcSEcCtD
Linagliptin—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000266	0.00114	CcSEcCtD
Linagliptin—Rash—Prednisolone—atopic dermatitis	0.000254	0.00109	CcSEcCtD
Linagliptin—Dermatitis—Prednisolone—atopic dermatitis	0.000253	0.00108	CcSEcCtD
Linagliptin—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000252	0.00108	CcSEcCtD
Linagliptin—Headache—Prednisolone—atopic dermatitis	0.000252	0.00108	CcSEcCtD
Linagliptin—Constipation—Prednisone—atopic dermatitis	0.00025	0.00107	CcSEcCtD
Linagliptin—Rash—Hydrocortisone—atopic dermatitis	0.000248	0.00106	CcSEcCtD
Linagliptin—Dermatitis—Hydrocortisone—atopic dermatitis	0.000247	0.00106	CcSEcCtD
Linagliptin—Headache—Hydrocortisone—atopic dermatitis	0.000246	0.00105	CcSEcCtD
Linagliptin—Rash—Triamcinolone—atopic dermatitis	0.000233	0.000998	CcSEcCtD
Linagliptin—Dermatitis—Triamcinolone—atopic dermatitis	0.000233	0.000997	CcSEcCtD
Linagliptin—Rash—Methylprednisolone—atopic dermatitis	0.000233	0.000996	CcSEcCtD
Linagliptin—Dermatitis—Methylprednisolone—atopic dermatitis	0.000232	0.000995	CcSEcCtD
Linagliptin—Urticaria—Prednisone—atopic dermatitis	0.000232	0.000994	CcSEcCtD
Linagliptin—Headache—Triamcinolone—atopic dermatitis	0.000232	0.000992	CcSEcCtD
Linagliptin—Headache—Methylprednisolone—atopic dermatitis	0.000231	0.00099	CcSEcCtD
Linagliptin—Diarrhoea—Betamethasone—atopic dermatitis	0.00023	0.000983	CcSEcCtD
Linagliptin—Diarrhoea—Dexamethasone—atopic dermatitis	0.00023	0.000983	CcSEcCtD
Linagliptin—Hypersensitivity—Prednisone—atopic dermatitis	0.000215	0.000922	CcSEcCtD
Linagliptin—Rash—Betamethasone—atopic dermatitis	0.000212	0.000906	CcSEcCtD
Linagliptin—Rash—Dexamethasone—atopic dermatitis	0.000212	0.000906	CcSEcCtD
Linagliptin—Dermatitis—Dexamethasone—atopic dermatitis	0.000211	0.000905	CcSEcCtD
Linagliptin—Dermatitis—Betamethasone—atopic dermatitis	0.000211	0.000905	CcSEcCtD
Linagliptin—Headache—Dexamethasone—atopic dermatitis	0.00021	0.0009	CcSEcCtD
Linagliptin—Headache—Betamethasone—atopic dermatitis	0.00021	0.0009	CcSEcCtD
Linagliptin—Diarrhoea—Prednisone—atopic dermatitis	0.0002	0.000856	CcSEcCtD
Linagliptin—Rash—Prednisone—atopic dermatitis	0.000184	0.000789	CcSEcCtD
Linagliptin—Dermatitis—Prednisone—atopic dermatitis	0.000184	0.000788	CcSEcCtD
Linagliptin—Headache—Prednisone—atopic dermatitis	0.000183	0.000784	CcSEcCtD
